http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014046415-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56820bbb13a42311271e147869a36d30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
filingDate 2013-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fc8b0575b2672b3e4951e5817246999
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b79514438de191e860fa96ee1810782
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a602b62c18204e4fdbb51aae05d27bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bdbb61cf4d2947ca2a47d2d91825548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fce9f1f820f126d1ac307cea7e3d4419
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa8831ada2044bb231f0a18cc77e6cd6
publicationDate 2014-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014046415-A1
titleOfInvention Method for preparing in situ-formed hydrogel using enzyme-immobilized support, and biomedical use thereof
abstract The present invention relates to a method for preparing a hydrogel, comprising the steps of: preparing an enzyme-immobilized support; making contacting with a polymer having a phenol or aniline functional group at a side chain and the support in the presence of hydrogen peroxide to cross-link the same; and obtaining a hydrogel by separating the enzyme-immobilized support. According to the present invention, a hydrogel is formed by cross-linking a polymer having a phenol or aniline functional group at a side chain through an enzyme-immobilized support, and thus a hydrogel containing no enzymes is obtained. Therefore, the biomedical application range of a hydrogel can be expanded since it is possible to overcome an in vivo stability problem such as an immune reaction caused by an enzyme.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115382533-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106750462-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112805306-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111443007-A
priorityDate 2012-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100076173-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227227829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226694645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73857778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226955845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87138360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21983346

Total number of triples: 30.